Detalles de la búsqueda
1.
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells.
Nature
; 578(7796): E21, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015546
2.
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells.
Nature
; 578(7793): 154-159, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31969705
3.
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
J Infect Dis
; 229(5): 1256-1265, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38207119
4.
Control of Simian Immunodeficiency Virus Infection in Prophylactically Vaccinated, Antiretroviral Treatment-Naive Macaques Is Required for the Most Efficacious CD8 T Cell Response during Treatment with the Interleukin-15 Superagonist N-803.
J Virol
; 96(20): e0118522, 2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190241
5.
Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.
J Virol
; 96(23): e0142422, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36377872
6.
IL-15 Superagonist N-803 Enhances IFN-γ Production of MAIT Cells in SIV+ Macaques.
Infect Immun
; 90(10): e0025922, 2022 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190256
7.
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques.
PLoS Pathog
; 16(3): e1008339, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32163523
8.
Combination of CD8ß Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
J Virol
; 94(19)2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669328
9.
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal.
J Virol
; 94(9)2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32051267
10.
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
J Infect Dis
; 222(4): 628-636, 2020 07 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31681963
11.
Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs.
J Virol
; 92(23)2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209173
12.
Relationships between Neutralization, Binding, and ADCC of Broadly Neutralizing Antibodies against Reservoir HIV.
J Virol
; 95(2)2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115874
13.
HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.
PLoS Med
; 11(4): e1001616, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24714363
14.
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
Science
; 383(6687): 1104-1111, 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38422185
15.
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques.
Nat Med
; 29(10): 2535-2546, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37783968
16.
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies.
Front Immunol
; 13: 910136, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35911728
17.
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial.
Nat Med
; 28(2): 392-400, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35102335
18.
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates.
Nat Med
; 8(2): 185-9, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11821904
19.
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244307
20.
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.
Sci Rep
; 11(1): 14917, 2021 07 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34290317